ArticleCureus2025
Primary Cesarean Section in Multigravida Women: Trends and Outcomes in a Tertiary Care Setting.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionA primary cesarean in a multigravida refers to the first cesarean section (CS) performed on a woman who has previously delivered vaginally at least once. This study aimed to assess the incidence and indications of primary CS in multigravida women and their feto-maternal outcomes. METHODOLOGY: This study was conducted in the Department of Obstetrics and Gynaecology, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India, from June 2022 to May 2024. A total of 5,280 women delivered in our department during this period, of whom 476 multiparous antenatal women undergoing primary CS were evaluated.
resultsThe incidence of primary CS in multigravida women was 39.47%, most of which were emergency CS. The most common indication for CS was fetal distress (26.47%), followed by malpresentation in 21.43% of women. Among the feto-maternal complications, 21.85% of women developed complications such as transfusion reaction (12.18%), upper respiratory tract infection (URTI) in 8.19%, puerperal pyrexia in 5.46%, and postpartum hemorrhage in 4.20% of women. Respiratory distress syndrome was the most common cause of neonatal morbidity (6.93%).
conclusionMultiparity increases the risk of complications in the antepartum and intrapartum periods, necessitating operative interventions in certain conditions. Efficient antenatal evaluation and early identification and management of high-risk women can help decrease the incidence of unwarranted complications leading to emergency cesareans in multigravida patients. Additionally, regular audits of the same can help optimize the incidence of CS in these women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.